These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 28467989

  • 1. Mir-338-3p Mediates Tnf-A-Induced Hepatic Insulin Resistance by Targeting PP4r1 to Regulate PP4 Expression.
    Dou L, Wang S, Sun L, Huang X, Zhang Y, Shen T, Guo J, Man Y, Tang W, Li J.
    Cell Physiol Biochem; 2017; 41(6):2419-2431. PubMed ID: 28467989
    [Abstract] [Full Text] [Related]

  • 2. Protein phosphatase 4 (PP4) functions as a critical regulator in tumor necrosis factor (TNF)-α-induced hepatic insulin resistance.
    Zhao H, Huang X, Jiao J, Zhang H, Liu J, Qin W, Meng X, Shen T, Lin Y, Chu J, Li J.
    Sci Rep; 2015 Dec 15; 5():18093. PubMed ID: 26666849
    [Abstract] [Full Text] [Related]

  • 3. MiR-499-5p Contributes to Hepatic Insulin Resistance by Suppressing PTEN.
    Wang L, Zhang N, Pan HP, Wang Z, Cao ZY.
    Cell Physiol Biochem; 2015 Dec 15; 36(6):2357-65. PubMed ID: 26279439
    [Abstract] [Full Text] [Related]

  • 4. MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression.
    Dou L, Wang S, Sui X, Meng X, Shen T, Huang X, Guo J, Fang W, Man Y, Xi J, Li J.
    Cell Physiol Biochem; 2015 Dec 15; 35(4):1413-24. PubMed ID: 25790935
    [Abstract] [Full Text] [Related]

  • 5. miR‑338‑3p mediates gluconeogenesis via targeting of PP4R1 in hepatocytes.
    Wang S, Li L, Chen X, Huang X, Liu J, Sun X, Zhang Y, Shen T, Guo J, Man Y, Tang W, Dou L, Li J.
    Mol Med Rep; 2018 Oct 15; 18(4):4129-4137. PubMed ID: 30132533
    [Abstract] [Full Text] [Related]

  • 6. Hepatic MiR-291b-3p Mediated Glucose Metabolism by Directly Targeting p65 to Upregulate PTEN Expression.
    Guo J, Dou L, Meng X, Chen Z, Yang W, Fang W, Yang C, Huang X, Tang W, Yang J, Li J.
    Sci Rep; 2017 Jan 05; 7():39899. PubMed ID: 28054586
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA 152 regulates hepatic glycogenesis by targeting PTEN.
    Wang S, Wang L, Dou L, Guo J, Fang W, Li M, Meng X, Man Y, Shen T, Huang X, Li J.
    FEBS J; 2016 May 05; 283(10):1935-46. PubMed ID: 26996529
    [Abstract] [Full Text] [Related]

  • 8. Hepatic miR-125b inhibits insulin signaling pathway by targeting PIK3CD.
    Du X, Li X, Chen L, Zhang M, Lei L, Gao W, Shi Z, Dong Y, Wang Z, Li X, Liu G.
    J Cell Physiol; 2018 Aug 05; 233(8):6052-6066. PubMed ID: 29319168
    [Abstract] [Full Text] [Related]

  • 9. Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte.
    Wu J, Dong T, Chen T, Sun J, Luo J, He J, Wei L, Zeng B, Zhang H, Li W, Liu J, Chen X, Su M, Ni Y, Jiang Q, Zhang Y, Xi Q.
    Metabolism; 2020 Feb 05; 103():154006. PubMed ID: 31715176
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-20a-5p contributes to hepatic glycogen synthesis through targeting p63 to regulate p53 and PTEN expression.
    Fang W, Guo J, Cao Y, Wang S, Pang C, Li M, Dou L, Man Y, Huang X, Shen T, Li J.
    J Cell Mol Med; 2016 Aug 05; 20(8):1467-80. PubMed ID: 27019188
    [Abstract] [Full Text] [Related]

  • 11. Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid.
    Yang YM, Seo SY, Kim TH, Kim SG.
    Hepatology; 2012 Dec 05; 56(6):2209-20. PubMed ID: 22807119
    [Abstract] [Full Text] [Related]

  • 12. Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1.
    Wang S, Liang C, Ai H, Yang M, Yi J, Liu L, Song Z, Bao Y, Li Y, Sun L, Zhao H.
    Dig Dis Sci; 2019 Jun 05; 64(6):1548-1559. PubMed ID: 30627917
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of miR-497 induces hepatic insulin resistance in E3 rats with HFD-MetS by targeting insulin receptor.
    Wang X, Wang M, Li H, Lan X, Liu L, Li J, Li Y, Li J, Yi J, Du X, Yan J, Han Y, Zhang F, Liu M, Lu S, Li D.
    Mol Cell Endocrinol; 2015 Nov 15; 416():57-69. PubMed ID: 26300412
    [Abstract] [Full Text] [Related]

  • 14. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K, Ryu D, Dongiovanni P, Ozcan L, Nayak S, Ueberheide B, Valenti L, Auwerx J, Pajvani UB.
    Gastroenterology; 2017 Dec 15; 153(6):1568-1580.e10. PubMed ID: 28859855
    [Abstract] [Full Text] [Related]

  • 15. Pseudogene PTENP1 Functions as a Competing Endogenous RNA (ceRNA) to Regulate PTEN Expression by Sponging miR-499-5p.
    Wang L, Zhang N, Wang Z, Ai DM, Cao ZY, Pan HP.
    Biochemistry (Mosc); 2016 Jul 15; 81(7):739-47. PubMed ID: 27449620
    [Abstract] [Full Text] [Related]

  • 16. MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes.
    Dou L, Meng X, Sui X, Wang S, Shen T, Huang X, Guo J, Fang W, Man Y, Xi J, Li J.
    Sci Rep; 2015 Jun 26; 5():11602. PubMed ID: 26111969
    [Abstract] [Full Text] [Related]

  • 17. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
    Zhu X, Li H, Wu Y, Zhou J, Yang G, Wang W.
    Int J Mol Med; 2019 Jan 26; 43(1):345-357. PubMed ID: 30431065
    [Abstract] [Full Text] [Related]

  • 18. A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis.
    Xiao F, Yu J, Liu B, Guo Y, Li K, Deng J, Zhang J, Wang C, Chen S, Du Y, Lu Y, Xiao Y, Zhang Z, Guo F.
    Diabetes; 2014 Aug 26; 63(8):2631-42. PubMed ID: 24677715
    [Abstract] [Full Text] [Related]

  • 19. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells.
    Dong L, Hou X, Liu F, Tao H, Zhang Y, Zhao H, Song G.
    Cell Biol Int; 2019 May 26; 43(5):553-564. PubMed ID: 30958584
    [Abstract] [Full Text] [Related]

  • 20. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, Chen Q, Li YH, Wang JJ, Kang YM, Zhu GQ.
    Clin Sci (Lond); 2015 Nov 26; 129(10):839-50. PubMed ID: 26201094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.